Purpose: Data on the efficacy and safety of stereotactic radiosurgery (SRS) for treatment of radiation-induced meningiomas (RIMs) are limited.

Methods: A single institution database of Cobalt-60 SRS cases from 08/1999 to 10/2020 was reviewed. Radiation-induced meningiomas were identified using Cahan's criteria. Endpoints included overall survival (OS), progression free survival (PFS), local control (LC), treatment failure, and treatment toxicity. Univariate and multivariate analyses were performed using cox proportional hazard models.

Results: A total of 29 patients with 86 RIM lesions were identified. Median follow-up after SRS was 59 months. The median dose prescribed to the 50% isodose line was 14 Gy (range 12-20 Gy). The actuarial 5-yr OS and PFS were 96% and 68%, respectively. Patients treated for recurrent RIMs had a significantly lower PFS (45% vs 94% at 3 yr, p < 0.005) than patients treated in the upfront setting. Patients with presumed or WHO grade I RIMs had a significantly greater PFS (3-year PFS 96% vs 20%) than patients with WHO grade II RIMs (p < 0.005). On a per-lesion basis, local control (LC) at 1-, 3-, and 5-yrs was 82%, 76%, 74%, respectively. On multivariate analysis, female gender was associated with improved LC (p < 0.001), while marginal doses > 14 Gy were associated with worse local control (p < 0.001). Grade I-III toxicity following treatment was 9.0%.

Conclusions: Stereotactic radiosurgery is a safe and effective treatment option for radiographic RIMs, WHO grade I RIMs, or lesions treated in the upfront setting. WHO grade II lesions and recurrent lesions are at increased risk for disease progression.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-022-04156-8DOI Listing

Publication Analysis

Top Keywords

radiation-induced meningiomas
12
stereotactic radiosurgery
8
outcomes radiation-induced
4
meningiomas treated
4
treated stereotactic
4
radiosurgery purpose
4
purpose data
4
data efficacy
4
efficacy safety
4
safety stereotactic
4

Similar Publications

Article Synopsis
  • Intraoperative real-time fluorescence navigation using indocyanine green (ICG) has been successfully used for various brain tumors but has not been explored for radiation-induced brain necrosis, which poses surgical challenges due to its diffuse nature.
  • A study involved four patients with necrotic brain tissues, who received ICG before surgery; near-infrared fluorescence was used to locate the necrotic areas, providing a clear visual contrast during resection.
  • The findings indicate that ICG fluorescence imaging effectively identified radiation-induced necrotic tissues during surgery, marking a significant advancement in surgical techniques for this condition.
View Article and Find Full Text PDF

Analysis of safety and efficacy of proton radiotherapy for optic nerve sheath meningioma.

Neurooncol Adv

September 2024

Heidelberg Ion-Beam Therapy Center (HIT), Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg University, Heidelberg, Germany.

Article Synopsis
  • Primary optic nerve sheath meningiomas (ONSMs) are benign tumors that can cause gradual vision loss, and radiation therapy, particularly proton therapy, is key for treatment as it may improve visual function while minimizing side effects.* -
  • In a study of 32 patients treated with proton beam radiotherapy, results showed a 100% local control rate after 5 years and 84.4% of patients experienced improved or stable vision, despite a 9.4% occurrence of radiation-induced optic neuropathy (RION).* -
  • The findings support proton beam therapy as a safe and effective option for ONSM treatment, though further research is needed to compare its effectiveness against traditional photon radiotherapy.*
View Article and Find Full Text PDF
Article Synopsis
  • This study looked at the safety and effectiveness of a treatment called Gamma-knife stereotactic radiosurgery (SRS-GK) for a type of brain tumor called radiation-induced meningiomas (RIMs) at a hospital in Italy.
  • They included data from 13 patients and found that 26% improved, while 52% stayed the same and 22% got worse, with a good control rate over 5 years.
  • In a bigger analysis, including 146 patients, the overall success rate was high, but some patients experienced side effects like swelling, showing that while SRS-GK works well, there can be risks involved.
View Article and Find Full Text PDF

Introduction: Radiation-induced gliomas (RIGs) were reported in the literature in general. In most of the reported cases and the reviewed articles, patients have a history of primary intracranial tumors like craniopharyngioma, medulloblastoma, and ependymoma, and the commonly resulting secondary tumors are meningiomas and sarcomas, mainly not gliomas. .

View Article and Find Full Text PDF

Patients with radiation-induced meningioma (RIM), most of whom had received head radiation therapy or had been exposed to ionizing radiation during childhood or adolescence, are at risk of developing cranial meningiomas throughout their lifetimes because of the long latency period. Although intermediate-to-high-dose ionizing radiation exposure is an established risk factor for RIM, risk factors for low-dose RIM remain incompletely defined. This study presents the case of a 56-year-old woman diagnosed with radiation-induced giant meningioma 2.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!